Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
GeneDx Holdings Corp. is a genomics company specializing in genetic testing services for pediatric and rare diseases. Their main offerings include whole exome and genome sequencing, alongside data and information services, and an AI-powered platform for analyzing next-generation sequencing data. GeneDx aims to improve diagnostics and reporting for hereditary conditions and cancer.
AI-generated summary. Not investment advice.